Breast cancer gene-expression blood test

Thursday, 01 January, 2009 | Supplied by: Applied Biosystems Pty Ltd

DiaGenic and Applied Biosystems have launched BCtect, a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature using a custom TaqMan array.

The test uses peripheral blood rather than tissue from the actual breast, providing a less invasive method of testing. It is also not affected by ethnic variation or the menopausal state of the patient, allowing for widespread use to diagnose breast cancer at an early stage.

The TaqMan Array consists of 96 TaqMan gene expression assays pre-loaded multiple times on a 384-well microfluidic card. These 384 simultaneous, real-time PCR reactions are performed without the need to use liquid-handling robots or multichannel pipettors. The array is run on the 7900HT Fast Real-time PCR System by Labindia.


Phone: 03 9730 8600
Related Products

Molecular Innovations Human Alpha-1-Antitrypsin Total Antigen ELISA Kit

Molecular Innovations' Human Alpha-1-Antitrypsin ELISA Kit is for the sensitive quantitative...

PerkinElmer LabChip Extended Range N-Linked Glycan Assay

The LabChip Extended Range N-Linked Glycan Assay enables the high-throughput sizing and...

GeneCopoeia OmicsArray protein microarrays

GeneCopoeia's OmicsArray protein microarrays are powerful tools for many applications,...

  • All content Copyright © 2020 Westwick-Farrow Pty Ltd